| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 124,800 | $1 | $499.2K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,200 | $30 | $336.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,870 | $30 | $204.5K |
| J3262 | Injection, tocilizumab, 1 mg | 38,080 | $10 | $190.4K |
| J0897 | Injection, denosumab, 1 mg | 9,540 | $20 | $171.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,890 | $10 | $108.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 510 | $80 | $42.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 570 | $60 | $31.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $90 | $25.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $110 | $13.5K |